Pulmonx (LUNG) Net Cash Flow (2019 - 2025)
Pulmonx (LUNG) reported Net Cash Flow of $700000.0 for Q3 2025, up 6900.0% year-over-year from $10000.0 in Q3 2024, and down 53.46% on a QoQ basis from $1.5 million in Q2 2025.
Pulmonx (LUNG) has 7 years of Net Cash Flow data on file, last reported at $700000.0 in Q3 2025.
- Quarterly Net Cash Flow rose 6900.0% year-over-year to $700000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $6.0 million (up 147.1% YoY) and the FY2024 annual result came in at -$12.7 million, up 30.26% from the prior year.
- Net Cash Flow declined to $700000.0 in Q3 2025 per LUNG's latest filing, from $1.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $8.7 million in Q1 2023 and bottomed at -$39.7 million in Q4 2021.
- The 5-year median for Net Cash Flow is -$8.6 million (2023), against an average of -$8.2 million.
- The widest annual swing landed in 2021, when Net Cash Flow sank 1550.26%; it then jumped 6900.0% in 2025.
- Tracing LUNG's Net Cash Flow over 5 years: stood at -$39.7 million in 2021, then surged by 73.62% to -$10.5 million in 2022, then fell by 6.42% to -$11.1 million in 2023, then soared by 166.37% to $7.4 million in 2024, then sank by 90.53% to $700000.0 in 2025.
- Per Business Quant, the three latest LUNG Net Cash Flow figures stand at $700000.0 (Q3 2025), $1.5 million (Q2 2025), and $3.8 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 3.78 Mn |
| Mar 31, 2025 | 3.78 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Dec 31, 2024 | 7.39 Mn |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | -6.66 Mn |
| Jun 30, 2024 | -6.66 Mn |
| Mar 31, 2024 | -13.44 Mn |
| Mar 31, 2024 | -13.44 Mn |
| Dec 31, 2023 | -11.14 Mn |
| Dec 31, 2023 | -11.14 Mn |
| Sep 30, 2023 | -7.14 Mn |
| Sep 30, 2023 | -7.14 Mn |
| Jun 30, 2023 | -8.62 Mn |
| Jun 30, 2023 | -8.62 Mn |
| Mar 31, 2023 | 8.69 Mn |
| Mar 31, 2023 | 8.69 Mn |
| Dec 31, 2022 | -10.47 Mn |
| Dec 31, 2022 | -10.47 Mn |
| Sep 30, 2022 | -9.74 Mn |
| Sep 30, 2022 | -9.74 Mn |
| Jun 30, 2022 | -7.35 Mn |
| Jun 30, 2022 | -7.35 Mn |
| Mar 31, 2022 | -19.33 Mn |
| Mar 31, 2022 | -19.33 Mn |
| Dec 31, 2021 | -39.67 Mn |
| Dec 31, 2021 | -39.67 Mn |
| Sep 30, 2021 | -10.71 Mn |
| Sep 30, 2021 | -10.71 Mn |
| Jun 30, 2021 | -10.59 Mn |
| Jun 30, 2021 | -10.59 Mn |
| Mar 31, 2021 | -22.22 Mn |
| Mar 31, 2021 | -22.22 Mn |
| Dec 31, 2020 | 191.81 Mn |
| Dec 31, 2020 | 191.81 Mn |
| Sep 30, 2020 | -3.59 Mn |
| Sep 30, 2020 | -3.59 Mn |
| Jun 30, 2020 | 27.14 Mn |
| Jun 30, 2020 | 27.14 Mn |
| Mar 31, 2020 | 1.53 Mn |
| Mar 31, 2020 | 1.53 Mn |
| Dec 31, 2019 | -864,000.00 |
| Dec 31, 2019 | -864,000.00 |